The population distributions for age, sex, Killip classification, family history of CAD, hypertension, hyperlipidemia, current/recent smoker, CKD, prior congestive heart failure (CHF), atrial fibrillation/flutter, cerebrovascular disease, HbA1c, proBNP, hemoglobin (Hb), hsCRP, lipid profile, the use of antiplatelet agents, beta blocker, calcium channel blocker, statin, glycoprotein (Gp) IIb/IIIa inhibitor and left ventricular ejection fraction (LVEF) significantly differed among the three groups. This evidence concerns the gene GSTM1 and hypertensive disorder.